目的：完善《药品管理法》修订，以加强医疗机构药品监管。
Objective:The consummation《Pharmaceutical Administration Law》revises, strengthens the Medical institutions drugs supervision.
目的建立我国药品不良反应救济制度，使《药品管理法》更加完善。
Objective To perfect drug administration law of the People's Republic of China by establishing the adverse drug reaction (ADR) relief system.
随着新的《药品管理法》的实施，各类药品都将有一个效期管理的问题存在。
With the implementation of the new Law of Drug Control, the problem of expiry date has come to draw public attention.
结合基层药品监督管理工作实际，就医疗机构配用药品的管理和《药品管理法》的修改提出建议。
Some Suggestions are offered on the management of drug purchasing in medical units and the revising of drug Administrative Law.
结果与结论现行《药品管理法》中的假药定义不能有效地适用于各种类型药品的假药判定，需要进行改进。
Results and Conclusions The definition of counterfeit drugs in the Drug Administration Law of China is not applicable to various types of drugs. The definition need to be amended.
方法从药品不良反应、药品不良反应损害救济，以及现行《药品管理法》的法律缺失造成的社会问题出发，探讨如何从完善法律这一层面解决药品不良反应损害引发的问题。
Methods Discussion on how to solve ADR harm by revising the legal provision from the perspective of ADR and relief for it, and the social problems result from legal provision absence.
方法从药品不良反应、药品不良反应损害救济，以及现行《药品管理法》的法律缺失造成的社会问题出发，探讨如何从完善法律这一层面解决药品不良反应损害引发的问题。
Methods Discussion on how to solve ADR harm by revising the legal provision from the perspective of ADR and relief for it, and the social problems result from legal provision absence.
应用推荐